Divestments
Aldevron
The leading global supplier of plasmid DNA used in cell and gene therapies.
Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA.
- Sector
Healthcare
- Country
United States
- Fund
EQT VIII
- Entry
2019
- Exit
2024
Website
Responsible Advisor
Eric Liu
About Aldevron
Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. The company’s mission is to develop and manufacture biologics at the highest quality that help make meaningful changes worldwide, and its custom development and manufacturing capabilities enable scientists to develop groundbreaking new therapies. Aldevron is based in Fargo, North Dakota and has additional operations in Madison, Wisconsin and Freiburg, Germany. The Company serves leading academic and research institutions, pharmaceutical and biotechnology companies.
Latest News From EQT
Do You Want to Know More?
We are eager to explore how we can achieve great things together.